Sign In
Buy ABT
$90.53
+2.76 (+3.14%)
At Close: Jun 23, 2026
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
02:45pm, Tuesday, 22'nd Nov 2022 The Motley Fool
The pharmaceutical company's golden goose is about to stop laying golden eggs, but that won't be a permanent problem.
Want Passive Income in 2023? Buy These Dividend Kings
11:00am, Tuesday, 22'nd Nov 2022 The Motley Fool
These stocks offer you a gift: recurrent income just for owning them.
Good Stocks To Invest In Now? 3 Dividend Aristocrats Stocks For Your List
06:30am, Tuesday, 22'nd Nov 2022
Check out these three dividend aristocrats in the stock market this week.
Want Passive Income in 2023? Buy These Dividend Kings
06:00am, Tuesday, 22'nd Nov 2022
These stocks offer you a gift: recurrent income just for owning them.
4 Growth Stocks To Buy As Inflation Cools
01:17pm, Monday, 21'st Nov 2022
Inflation cooled more than expected recently. It could be the first sign of a different rate environment and a bullish stock market. These four stocks should profit either way due to their strong grow
Abbott Laboratories: Prepare For A Tough 2023
01:01am, Monday, 21'st Nov 2022
The stock of Abbott Labs is down 18%+ over the past 12 months and has significantly underperformed the broad healthcare sector. This is likely not what investors expected - typically a healthcare stoc
Abbott (ABT) Up 7.7% Since Last Earnings Report: Can It Continue?
04:30pm, Friday, 18'th Nov 2022 Zacks Investment Research
Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Abbott (ABT) Up 7.7% Since Last Earnings Report: Can It Continue?
12:56pm, Friday, 18'th Nov 2022
Abbott (ABT) reported earnings 30 days ago. What's next for the stock?
Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q3 2022 Update
08:03am, Friday, 18'th Nov 2022 Seeking Alpha
Bridgewater Associates’ 13F portfolio value decreased from ~$23.60B to ~$19.75B this quarter. They increased Visa, Mondelez International, MasterCard, and Alphabet.
3 Reasons to Retain Abbott (ABT) Stock in Your Portfolio
03:16pm, Thursday, 17'th Nov 2022 Zacks Investment Research
Investors continue to be optimistic about Abbott (ABT) owing to the strength in its Diabetes business.
Is Most-Watched Stock Abbott Laboratories (ABT) Worth Betting on Now?
10:32am, Tuesday, 15'th Nov 2022
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
7 No-Brainer Blue-Chip Stocks to Buy for 2023 and Beyond
12:05pm, Saturday, 12'th Nov 2022
While it's tempting to target the flavors of the week during a market correction, investors ought to spare some time for no-brainer blue-chip stocks to buy for 2023 and beyond. Indeed, the broader mar
Better Buy: Johnson & Johnson vs. Abbott Laboratories
02:37pm, Thursday, 10'th Nov 2022 The Motley Fool
These two healthcare giants are among the safest stocks investors can buy right now.
3 Top Healthcare Stocks Defying the Bear Market
11:05am, Thursday, 10'th Nov 2022 The Motley Fool
These healthcare companies haven't been slowed by macroeconomic conditions.
Better Buy: Johnson & Johnson vs. Abbott Laboratories
09:37am, Thursday, 10'th Nov 2022
These two healthcare giants are among the safest stocks investors can buy right now.
